Джозеф Меркола - Кето-диета. Революционная система питания, которая поможет похудеть и «научит» ваш организм превращать жиры в энергию

14. }. Yao and R. D. Brinton, “Targeting Mitochondrial Bioenergetics for Alzheimer’s Prevention and Treatment,” Current Pharmaceutical Design, 17, no. 31 (2011): 3474–3479, PMID: 21902662.

15. J. M. Hootman et al., “Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015–2040.” Arthritis & Rheumatololgy , 68, no. 7 (July 2016): 1582–1587, DOI: 10.1002/art.39692.

16. Knott et al., “Regulation of Osteoarthritis by Omega-3 (n-3) Polyunsaturated Fatty Acids in a Naturally Occurring Model of Disease.”

17. Y. M. Bastiaansen-Jenniskens et al., “Monounsaturated and Saturated, but Not n-6 Polyunsaturated Fatty Acids Decrease Cartilage Destruction under Inflammatory Conditions: A Preliminary Study.” Cartilage , 4 no. 4 (2013), 321–328. DOI: 10.1177/1947603513494401.

18. D. N. Ruskin, M. Kawamura, and S. A. Masino, “Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet,” PLoS One , 4, no. 12 (2009): e8349, D01:10.1371/journal.pone.0008349.

19. S. A. Masino and D. N. Ruskin, “Ketogenic Diets and Pain,” Journal of Child Neurology, 28, no. 8 (2013): 993-1001. DOI: 10.1177/0883073813487595.

20. “Vital Signs: Preventable Deaths from Heart Disease & Stroke,” Centers for Disease Control and Prevention, http://www.cdc.gov/dhdsp/vital_signs.htm, accessed November 28, 2016.

21. B. Hoogwerf et al., “Blood Glucose Concentrations <125 mg/dl and Coronary Heart Disease Risk J American Journal of Cardiology , 89, no. 5, (2002): 596–599, DOI: 10.1016/S0002-9149(01)02302-5.

22. N. V Dhurandhar and D. Thomas, “The Link between Dietary Sugar Intake and Cardiovascular Disease Mortality: An Unresolved Question,” Journal of the American Medical Association , 313, no. 9 (2015): 959–960. DOI: 10.1001/jama.2014.18267, accessed 12/2/16.

23. Q. Yang et al., “Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults,” JAMA Internal Medicine , 174, no. 4 (2014), 516–524, DOI: 10.1001/ jamainternmed.2013.13563.

24. L. Schwingshackl et al., “Comparison of Effects of Long-Term Low-Fat vs High-Fat Diets on Blood Lipid Levels in Overweight or Obese Patients: A Systematic Review and Meta-Analysis.” Journal of the Academy of Nutrition and Dietetics , 113, no. 12 (2013), 1640–1661, DOI: 10.1016/j.jand.2013.07.010.

25. C. L. Gibson, A. N. Murphy, and S. P. Murphy, “Stroke Outcome in the Ketogenic State: A Systematic Review of the Animal Data,” Journal of Neurochemistry, 123, no. 2 (2012), 52–57, DOI: 10.1111/j.l471-4159.2012.07943.x.

26. “Epilepsy Fast Facts,” Centers for Disease Control and Prevention, http://www.cdc. gov/epilepsy/basics/fast-facts.htm, accessed November 28, 2016.

27. J. W. Wheless, “History of the Ketogenic Diet,” Epilepsia, 49, Suppl. 8 (November 2008): 3–5, DOI: 10.111 l/j.1528–1167.2008.01821.x.

28. K. Martin et al, “Ketogenic Diet and Other Dietary Treatments for Epilepsy,” Cochrane Database of Systematic Reviews, 2 (2016), DOI: 10.1002/14651858. CD001903.pub3.

29. “What Is Fibromyalgia?” (November 2014), http://www.niams.nih.gov/.

30. Mayo Clinic, “Diseases and Conditions: Fibromyalgia,” http://www.mayoclinic. org/diseases-conditions/fibromyalgia/basics/causes/con-20019243, accessed November 28, 2016.

31. Paper presented at the Annual Meeting of the American College of Nutrition in Orlando, Florida, October 2001.

32. M. Meeus et al., “The Role of Mitochondrial Dysfunctions Due to Oxidative and Nitrosative Stress in the Chronic Pain or Chronic Fatigue Syndromes and Fibromyalgia Patients: Peripheral and Central Mechanisms as Therapeutic Targets?” Expert Opinion on Therapeutic Target, 17, no. 9 (2013): 1081–1089, DOI: 10.1517/14728222.2013.818657.

33. A. Ernst and J. Shelley-Tremblay, “Non-Ketogenic, Low Carbohydrate Diet Predicts Lower Affective Distress, Higher Energy Levels and Decreased Fibromyalgia Symptoms in Middle-Aged Females with Fibromyalgia Syndrome as Compared to the Western Pattern Diet,” Journal of Musculoskeletal Pain, 21, no. 4 (2013): 365–370, DOI: 10.3109/10582452.2013.852649.

34. “GERD,” American Gastroenterological Association, http://www.gastro.org/pa-tient-care/conditions-diseases/gerd, accessed November 28, 2016.

35. “A Sunny Day in Pharmaland: The 2015 Pharma Report,” Medical Marketing & Media, http://media.mmm-online.com/documents/119/pharma_report_2015_29732. pdf, accessed November 28, 2016.

36. Singh et al., “Weight Loss Can Lead to Resolution of Gastroesophageal Reflux Disease Symptoms: A Prospective Intervention Trial,” Obesity, 21, no. 2 (2013), DOI: 10.1002/oby.20279.

37. G. L. Austin et al., “A Very Low-Carbohydrate Diet Improves Gastroesophageal Reflux and Its Symptoms,” Digestive Diseases and Sciences, 51, no. 8 (August 2006): 1307–1312, DOI: 10.1007/sl0620-005-9027-7.

38. Singh et al., “Weight Loss Can Lead to Resolution of Gastroesophageal Reflux Disease Symptoms.”

39. G. L. Austin et al., “A Very Low-Carbohydrate Diet Improves Symptoms and Quality of Life in Diarrhea-Predominant Irritable Bowel Syndrome,” Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 7, no. 6 (2009): 706–708. el. DOI: 10.1016/j. cgh.2009.02.023.

40. Z. Zheng et al., “Staple Foods Consumption and Irritable Bowel Syndrome in Japanese Adults: A Cross-Sectional Study,” PLoS One, 10, no. 3 (2015): eOl 19097, DOI: 10.1371/journal.pone.Ol 19097.

41. “Migraine Statistics,” Migraine.com, https://migraine.com/migraine-statistics/, accessed November 28, 2016.

42. PubMed.gov, https://www.ncbi.nlm.nih.gov/pubmed/?term=migraine+food-i-allergy, accessed November 28, 2016.

43. K. Alpay et al., “Diet Restriction in Migraine, Based on IgG Against Foods: A Clinical Double-blind, Randomised, Cross-over Trial,” Cephalalgia , 30, no. 7 (2010): 829–837, DOI: 10.1177/0333102410361404.

44. C. Di Lorenzo et al., “Migraine Improvement During Short Lasting Ketogene-sis: A Proof-of-Concept Study,” European Journal of Neurology, 22, no. 1 (2015): 170–177, DOI: 10.1111/ene.l2550.

45. C. Di Lorenzo et al., “Diet Transiently Improves Migraine in Two Twin Sisters: Possible Role of Ketogenesis?” Functional Neurology , 28, no. 4 (2013): 305–308.

46. K. L. Munger et al., “Vitamin D Intake and Incidence of Multiple Sclerosis,” Neurology, 62, no. 1, (2004): 60–65, PMID: 14718698.

47. D. Y. Kim et al., “Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis,” PLoS One, 7, no. 5 (2012): e35476, DOI: 10.1371/journal.pone.0035476.

48. M. Storoni and G. T. Plant, “The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis,” Multiple Sclerosis International, 2015 (2015): 681289, DOI: 10.1155/2015/681289.

49. Там же.

50. “Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liv-erfoundation.org/abouttheliver/info/nafld/, accessed November 28, 2016.

51. S. S. Sundaram, “Pediatric Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liverfoundation.org/chapters/rockymountain/doctorsnotes/ pediatricnafld/, accessed November 28, 2016.

52. J. Ma et al., “Sugar-sweetened Beverage, Diet Soda, and Fatty Liver Disease in the Framingham Heart Study Cohorts,” Journal of Hepatology, 63, no. 2 (2015): 462–469, DOI: 10.1016/j.jhep.2015.03.032.

53. J. D. Browning et al., “Short-term Weight Loss and Hepatic Triglyceride Reduction: Evidence of a Metabolic Advantage with Dietary Carbohydrate Restriction,” The American Journal of Clinical Nutrition, 93, no. 5 (2011): 1048–1052. DOI: 10.3945/ajcn.l 10.007674.

54. J. Perez-Guisado and A. Munoz-Serrano, “The Effect of the Spanish Ketogenic Mediterranean Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Journal of Medicinal Food, 14, no. 7–8 (July-August 2011): 677–680, DOI: 10.1089/ jmf.2011.0075.

55. D. Tendler et al., “The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Digestive Diseases and Sciences , 52, no. 2 (February, 2007): 589–593, DOI: 10.1007/sl0620-006-9433-5.

56. P. Kennedy, “The Fat Drug.” The New York Times, March 8, 2014, http://www.ny-times.com/2014/03/09/opinion/sunday/the-fat-drug.html?_r=0, accessed 12/2/16.

57. H.-Y. Kim et al., “Phosphatidylserine-dependent Neuroprotective Signaling Promoted by Docosahexaenoic Acid,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, 82, no. 4–6 (2010): 165–172, DOI: 10.1016/j.plefa.2010.02.025.

58. H.-Y. Kim et al., “N-Docosahexaenoylethanolamide Promotes Development of Hippocampal Neurons,” The Biochemical Journal, 435, no. 2 (2011): 327–336, DOI: 10.1042/BJ20102118.

59. R. Palacios-Pelaez, W. J. Lukiw, and N. G. Bazan, “Omega-3 Essential Fatty Acids Modulate Initiation and Progression of Neurodegenerative Disease,” Molecular Neurobiology, 41, no. 2–3 (June 2010): 367–374, DOI: 10.1007/sl2035-010-8139-z.

60. Interview with J. J. Virgin, http://articles.mercola.com/sites/articles/ar-chive/2014/02/09/fish-oil-brain-health.aspx, accessed 12/2/16.

61. S. Smith, “Fish Oil Helped Save Our Son,” CNN, http://www.cnn.com/2012/10/19/ health/fish-oil-brain-injuries/index.html, accessed 12/2/16.

62. M. L. Prins and J. H. Matsumoto, “The Collective Therapeutic Potentialof Cerebral Ketone Metabolism in Traumatic Brain Injury,” Journal of Lipid Research, 55, no. 12 (2014): 2450–2457, DOI: 10.1194/jlr.R046706.

63. H. Algattas and J. H. Huang, “Traumatic Brain Injury Pathophysiology and Treatments: Early, Intermediate, and Late Phases Post-Injury,” International Journal of Molecular Sciences, 15, no. 1 (2014): 309–341, DOI: 10.3390/ijmsl5010309.

64. Там же.

65. M. L. Prins, L. S. Fujima, and D. A. Hovda, “Age-dependent Reduction of Cortical Contusion Volume by Ketones After Traumatic Brain Injury,” Journal of Neuroscience Research, 82, no. 3 (November 1, 2005): 413–420, DOI: 10.1002/jnr.20633.

66. Z. G. Hu et al., “The Protective Effect of the Ketogenic Diet on Traumatic Brain Injury-Induced Cell Death in Juvenile Rats,” Brain Injury, 23, no. 5 (2009): 459–465, DOI: 10.1080/02699050902788469.

67. “National Diabetes Statistics Report, 2014,” National Center for Chronic Disease Prevention and Health Promotion, http://www.cdc.gov/diabetes/pubs/statsre-portl4/national-diabetes-report-web.pdf, accessed 12/2/16.

68. “Diabetes Facts and Figures,” International Diabetes Foundation, http://www.idf. org/about-diabetes/facts-figures, accessed November 28, 2016.

69. D. Dabelea et al., “Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009,” Journal of the American Medical Association, 311, no. 17 (2014): 1778–1786, DOI: 10.1001/jama.2014.3201.

70. S. Vijan et al., “Effect of Patients’ Risks and Preferences on Health Gains with Glucose Lowering in Type 2 Diabetes,” JAMA Internal Medicine, 174, no. 8 (2014): 1227–1234, DOI: 10.1001/jamainternmed.2014.2894.

71. M. M. Poplawski et al., “Reversal of Diabetic Nephropathy by a Ketogenic Diet,” PLoS One , 6, no. 4 (2011): el8604, DOI: 10.1371/journal.pone.0018604.